These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32245796)

  • 21. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
    Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).
    Rao R; Rivers A; Rahimi A; Wooldridge R; Rao M; Leitch M; Euhus D; Haley BB
    Cancer; 2017 Jan; 123(1):107-113. PubMed ID: 27584945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.
    Martinez SR; Beal SH; Chen SL; Canter RJ; Khatri VP; Chen A; Bold RJ
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):787-92. PubMed ID: 20619550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer.
    Fejerman L; Hu D; Huntsman S; John EM; Stern MC; Haiman CA; Pérez-Stable EJ; Ziv E
    Cancer Res; 2013 Dec; 73(24):7243-53. PubMed ID: 24177181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
    Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
    Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.
    Sengal AT; Haj-Mukhtar NS; Elhaj AM; Bedri S; Kantelhardt EJ; Mohamedani AA
    BMC Cancer; 2017 Dec; 17(1):804. PubMed ID: 29191181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic admixture and risk of hypertensive disorders of pregnancy among Latinas in Los Angeles County.
    Shahabi A; Wilson ML; Lewinger JP; Goodwin TM; Stern MC; Ingles SA
    Epidemiology; 2013 Mar; 24(2):285-94. PubMed ID: 23344211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of triple-negative breast cancer, including race.
    Trivers KF; Lund MJ; Porter PL; Liff JM; Flagg EW; Coates RJ; Eley JW
    Cancer Causes Control; 2009 Sep; 20(7):1071-82. PubMed ID: 19343511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women.
    Linnenbringer E; Geronimus AT; Davis KL; Bound J; Ellis L; Gomez SL
    Breast Cancer Res Treat; 2020 Apr; 180(2):437-447. PubMed ID: 32002766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
    Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
    J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.
    Lund MJ; Butler EN; Hair BY; Ward KC; Andrews JH; Oprea-Ilies G; Bayakly AR; O'Regan RM; Vertino PM; Eley JW
    Cancer; 2010 Jun; 116(11):2549-59. PubMed ID: 20336785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
    Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
    Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C; Caggiano V
    Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple-negative breast cancers are increased in black women regardless of age or body mass index.
    Stead LA; Lash TL; Sobieraj JE; Chi DD; Westrup JL; Charlot M; Blanchard RA; Lee JC; King TC; Rosenberg CL
    Breast Cancer Res; 2009; 11(2):R18. PubMed ID: 19320967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil.
    Carvalho FM; Bacchi LM; Pincerato KM; Van de Rijn M; Bacchi CE
    BMC Womens Health; 2014 Aug; 14():102. PubMed ID: 25174527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.